Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000901309-00-000084
Filing Date
2000-02-11
Accepted
2000-02-11 00:00:00
Documents
2
Group Members
APERTURE ASSOCIATES LP ET ALAPERTURE ASSOCIATES, L.P.APERTURE PARTNERS, L.P.GARY L. BRIDGEHORSLEY BRIDGE PARTNERS, INC.N. DAN REEVES. PHILLIP HORSLEY

Document Format Files

Seq Description Document Type Size
1 SC 13G/A 23016
2 EXHIBIT 99.1 JOINT FIING STATEMENT EX-99 1930
  Complete submission text file 0000901309-00-000084.txt   27298
Mailing Address 505 MONTGOMERY STREET SAN FRANCISCO CA 94111
Business Address 505 MONTGOMERY STREET SAN FRANCISCO CA 94111 4159867733
APERTURE ASSOCIATES LP ET AL (Filed by) CIK: 0000937430 (see all company filings)

EIN.: 943128732 | State of Incorp.: DE | Fiscal Year End: 1231

Mailing Address 22026 20TH AVENUE SE, SUITE 102 22026 20TH AVENUE SE, SUITE 102 BOTHELL WA 98021
Business Address 22026 2OTH AVE SE STE 102 BOTHELL WA 98021 2064879500
SONUS PHARMACEUTICALS INC (Subject) CIK: 0000949858 (see all company filings)

EIN.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-45969 | Film No.: 534439
SIC: 2835 In Vitro & In Vivo Diagnostic Substances